What is Alamar Biosciences 's cash & equivalents?

Alamar Biosciences (ALMR) reported cash & equivalents of $64.59M in Q1 2026.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Alamar Biosciences ALMR Cash & Equivalents

Cash & Equivalents at other companies

Wintrust FinancialWTFC

$543.72M-11.8%

Tradeweb Markets Inc.TW

$1.94B+48.2%

eBayEBAY

$4.23B+1.9%

SEI InvestmentsSEIC

$363.15M-48.9%

Ally FinancialALLY

$11.23B-1.6%

Apollo Global ManagementAPO

$23.75B+53.1%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's cash & equivalents?: Alamar Biosciences (ALMR) reported cash & equivalents of $64.59M in Q1 2026.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.